The Report
Verified funding, headquarters, and leadership news from the world's most innovative businesses
19,292 reports and counting
Twist Bioscience secures $120M Series D for biotech innovation
Twist Bioscience raises $120M in Series D funding to advance its synthetic biology company manufacturing dna sequences and accelerate market growth.
NeuroPharma raises $190M Series B in September 2025 funding round
NeuroPharma secures $190M in Series B funding in September 2025, reaching $1.6B valuation to advance its neurological drug discovery using ai and machine learning.
BioSynth Labs raises $380M Series B in September 2025 funding round
BioSynth Labs secures $380M in Series B funding in September 2025, reaching $3.2B valuation to advance its synthetic biology platform for sustainable chemical manufacturing.
COUR Pharmaceuticals Raises $105M Series A to Transform Biotech
COUR Pharmaceuticals has secured $105M Series A in funding to accelerate growth and innovation in the biotech sector. Clinical-stage immunology company developing nanoparticle-based therapies for celiac disease and autoimmune conditions...
Latigo Biotherapeutics Raises $135M Series A to Transform Biotech
Latigo Biotherapeutics has secured $135M Series A in funding to accelerate growth and innovation in the biotech sector. Pain management company developing non-opioid therapies for chronic pain conditions...
Crystalys Therapeutics Raises $205M Series A to Transform Biotech
Crystalys Therapeutics has secured $205M Series A in funding to accelerate growth and innovation in the biotech sector. Clinical-stage biopharmaceutical company developing next-generation oral URAT1 inhibitor dotinurad for the treatment of ...
Peptilogics Raises $78M Series B2 to Transform Biotech
Peptilogics has secured $78M Series B2 in funding to accelerate growth and innovation in the biotech sector. Peptide therapeutics company developing macrocyclic peptides for challenging drug targets...
Azafaros Raises $146M Series B to Transform Biotech
Azafaros has secured $146M Series B in funding to accelerate growth and innovation in the biotech sector. Specialty pharmaceutical company advancing nizubaglustat for Gaucher disease and Parkinson's disease...
Abcuro Raises $200M Series C to Transform Biotech
Abcuro has secured $200M Series C in funding to accelerate growth and innovation in the biotech sector. Precision oncology company discovering and developing novel cancer immunotherapies targeting tumor microenvironments...
Showing 9 reports • Page 1 • Category: all
Stay ahead of the market
Get weekly insights delivered to your inbox. No spam, just intelligence.